BCOR abnormalities are pivotal in the pathogenesis of high-grade endometrial stromal sarcomas (ESS), particularly in the ZC3H7B-BCOR gene fusion subtype, which is associated with aggressive clinical behavior, high recurrence rates, and poor outcomes. The gene discussed is BCOR; the disease is endometrioid stromal sarcoma.